Cargando…

Tolerability of COVID-19 Vaccination in Patients with Mast Cell Activation

Detalles Bibliográficos
Autores principales:	Macdougall, Jessica, Amelio, Claire, Kwan, Mildred, Iweala, Onyinye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804463/ http://dx.doi.org/10.1016/j.jaci.2021.12.027

Ejemplares similares

Strategies for Mast Cell Inhibition in Food Allergy
por: Suber, Jada, et al.
Publicado: (2020)

The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome
por: Macdougall, Jessica D, et al.
Publicado: (2022)

Neighborhoods with 25% Minority Residents Are Still Mostly White
por: Spector, Andrew R., et al.
Publicado: (2021)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

T and B Lymphocyte Transcriptional States Differentiate between Sensitized and Unsensitized Individuals in Alpha-Gal Syndrome
por: Iweala, Onyinye I., et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with clonal mast cell disorders
por: Ruano-Zaragoza, Maria, et al.
Publicado: (2022)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

TET2 regulates immune tolerance in chronically activated mast cells
por: Rigo, Riccardo, et al.
Publicado: (2022)

COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022)

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial
por: Rutland, Cedric J, et al.
Publicado: (2023)

Safety of COVID‐19 vaccination in children with prior allergic reactions or mast cell disorders
por: Kulkarni, Rishabh, et al.
Publicado: (2023)

COVID-19 and Lung Mast Cells: The Kallikrein–Kinin Activation Pathway
por: Nagashima, Seigo, et al.
Publicado: (2022)

Mast cell activation is associated with post‐acute COVID‐19 syndrome
por: Wechsler, Joshua B., et al.
Publicado: (2021)

Basophils and Mast Cells in COVID-19 Pathogenesis
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Tolerability of a rapid‐escalation vinblastine‐prednisolone protocol in dogs with mast cell tumours
por: Serra Varela, Juan Carlos, et al.
Publicado: (2016)

LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells
por: De Zuani, Marco, et al.
Publicado: (2022)

Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis
por: Kazama, Itsuro
Publicado: (2021)

Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
por: Rosman, Yossi, et al.
Publicado: (2021)

Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty
por: Li, Xiangqi, et al.
Publicado: (2023)

Does IgE-mediated mast cell activation reduce oral tolerance to food antigens?
por: Tunis, M, et al.
Publicado: (2010)

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2020)

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2021)

Roles and relevance of mast cells in infection and vaccination
por: Fang, Yu, et al.
Publicado: (2016)

Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021)

Mast cell tolerance in the skin microenvironment to commensal bacteria is controlled by fibroblasts
por: Nardo, Anna Di, et al.
Publicado: (2023)

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)

Mast cell activation syndrome
por: Ratner, Vicki
Publicado: (2015)

Mast Cell Activation Disorders
por: Giannetti, Arianna, et al.
Publicado: (2021)

Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients
por: Budnevsky, Andrey V., et al.
Publicado: (2022)

Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
por: Folkerts, Jelle, et al.
Publicado: (2018)

Human placental extract suppresses mast cell activation and induces mast cell apoptosis
por: Wu, Tongqian, et al.
Publicado: (2023)

Tolerability and Effects of 2-Aminoethyl Dihydrogen Phosphate in Dogs With Mast Cell Tumors
por: Januário, Eric Vieira, et al.
Publicado: (2022)

Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance
por: Nakano, Toshiaki, et al.
Publicado: (2012)

Immunological dysfunction and mast cell activation syndrome in long COVID
por: Sumantri, Stevent, et al.
Publicado: (2023)

Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment
por: Kow, Chia Siang, et al.
Publicado: (2023)

Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations
por: Ricke, Darrell O.
Publicado: (2021)

THE MAST CELLS
Publicado: (1960)

Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy
por: Suber, Jada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ufdbe3m9uvn1ehl9glr14l8qj